ロード中...
IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy
IgA nephropathy (IgAN), characterized by mesangial IgA1 deposits, is a leading cause of renal failure worldwide. IgAN pathogenesis involves circulating hypogalactosylated IgA1 complexed with soluble IgA Fc receptor I (sCD89) and/or anti–hypogalactosylated-IgA1 autoantibodies, but no specific treatme...
保存先:
| 出版年: | J Am Soc Nephrol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Nephrology
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5004657/ https://ncbi.nlm.nih.gov/pubmed/26850635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015080856 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|